Politico August 15, 2024
Robert King, David Lim and Lauren Gardner

The result is a $6 billion savings across 10 drugs when new prices take effect in 2026, according to the White House.

The Biden administration on Thursday released the results of the first Medicare drug price negotiations, a milestone in Democrats’ decadeslong quest to have the nation’s largest payer use its leverage to lower prescription drug prices.

The result is a $6 billion savings across 10 drugs when new prices take effect in 2026, according to the White House, and beneficiaries will save roughly $1.5 billion in out-of-pocket costs.

“Empowering Medicare to negotiate prices not only strengthens the program for generations to come, but also puts a check on skyrocketing drug prices,” HHS Secretary Xavier Becerra said in a statement.

...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, CMS, Congress / White House, Govt Agencies, HHS, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech
Hospitals urge lawmakers to act as Medicare telehealth policies near expiration
Small practices, individual radiologists at a disadvantage in Medicare quality pay program
CMS Issues Final Rule on Returning Medicare and Medicaid Overpayments
Medicare Part D Spending on 10 Diabetes Drugs Hit $35.8B in 2023
Medicare Part D spending on weight loss drugs surges 364%: OIG

Share This Article